Nephron Pharmaceuticals Announces Leadership Transition

WEST COLUMBIA, S.C.–(BUSINESS WIRE)–Nephron LLC and its subsidiaries (“Nephron” or the “Company”) today announced the departure of Lou Kennedy from her role as Chief Executive Officer. Haywood Miller has been appointed Interim Chief Executive Officer, effective immediately. Nephron enters this next chapter with the strong support of its secured lenders, who share confidence in the Company’s transformation strategy, growth priorities, long-standing customer relationships, and resilient manufac

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.